Emerging smart mobile health (or mHealth) technologies are changing the way patients track information related to diagnosed conditions. A new study examined the health and economic impacts of
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. AMARYL® (am-a(r)-RILL) glimepiride (glim-epi-RIDE) Consumer Medicine Information (CMI) What is in this leaflet This leaflet
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. KOMBIGLYZE® XR Saxagliptin/metformin hydrochloride modified release Consumer Medicine Information What is in this leaflet This
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. APIDRA® (a-pid-ra) insulin glulisine (in-sue-lin glue-lee-seen) Consumer Medicine Information (CMI) What is in this leaflet
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. REVLIMID® (lenalidomide) Consumer Medicine Information WARNING: Revlimid (lenalidomide) is structurally related to ‘thalidomide’, which is
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. DIABEX* XR contains the active ingredient metformin hydrochloride CONSUMER MEDICINE INFORMATION What is in this
A change in breakfast routine may provide benefits for the management of type 2 diabetes, according to a new study published in the Journal of Dairy Science. H.
It’s no secret that late night noshing is bad for our waistlines. But according to a new study, it’s also detrimental to our health. New research from the
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok
